Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/9/2025

Treatment Guidelines for Postural Orthostatic Tachycardia Syndrome (POTS)

Non-Pharmacological Management

  • The American College of Cardiology recommends increasing daily fluid intake to 2-3 liters per day to maintain adequate hydration and blood volume 1
  • Increasing salt consumption to 5-10g (1-2 teaspoons) of table salt daily is recommended, preferring dietary sodium over salt tablets to minimize gastrointestinal side effects 1
  • Waist-high compression garments can improve venous return and reduce venous pooling 1
  • Elevating the head of the bed during sleep can help with fluid redistribution 1
  • Regular cardiovascular exercise, preferably in recumbent or semi-recumbent positions, starting with short duration and gradually increasing exercise duration is recommended 1

Pharmacological Management

  • For Hypovolemic POTS, fludrocortisone can be beneficial for volume expansion 1
  • Oral fluid loading has a pressor effect and may require less volume than intravenous fluid infusion 1
  • For Neuropathic POTS, midodrine (2.5-10 mg three times daily) can be used to enhance vascular tone 1
  • Pyridostigmine can be considered as an alternative to enhance vascular tone 1
  • For Hyperadrenergic POTS, propranolol or other beta-blockers can be used to treat resting tachycardia 1

Monitoring and Precautions

  • Monitoring for supine hypertension with vasoconstrictors like midodrine is recommended 1
  • Carefully adjusting or withdrawing medications that may cause hypotension is necessary 1
  • For heart rates as high as 180 bpm, considering cardiac evaluation to rule out other arrhythmias is recommended 1
  • Assessing response to treatment by monitoring standing heart rate and symptom improvement is necessary 1
  • Follow-up at regular intervals: early review at 24-48 hours, intermediate follow-up at 10-14 days, and late follow-up at 3-6 months is recommended 1

Management of Associated Conditions

  • For patients with chronic fatigue syndrome and POTS, considering coenzyme Q10 and d-ribose is recommended 1
  • For anxiety, which can exacerbate POTS symptoms, providing education about the physiological process of anxiety and its interaction with POTS is recommended 2
  • Teaching sensory grounding techniques to prevent dissociation during anxiety episodes is recommended 2
  • Implementing breathing techniques and progressive muscle relaxation is recommended 2
  • Considering SSRIs at low doses, titrated slowly for severe anxiety is recommended 2

Clinical Pearls

  • Recognizing that POTS is frequently associated with deconditioning, recent infections, chronic fatigue syndrome, and joint hypermobility syndrome is necessary 1
  • Avoiding medications that lower CSF pressure or reduce blood pressure as they may exacerbate postural symptoms is recommended 1
  • The European Society of Cardiology recognizes that syncope is rare in POTS and usually elicited by vasovagal reflex activation 3

REFERENCES

1

Treatment of Postural Orthostatic Tachycardia Syndrome (POTS) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Treatment of Anxiety in Patients with Postural Orthostatic Tachycardia Syndrome (POTS) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025